GSDME and neoplasm: Research has found that ALKBH4 can transcriptionally suppress GSDME activation by inhibiting H3K4me3 histone modifications at its promoter region, thereby reducing tumor cell sensitivity to 5-FU treatment (9), findings that highlight the importance of histone modifications in GSDME regulation.